NAUMAN TAJ: Open Payments
NPI 1942516539 · FORT COLLINS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,245 in 29 payments from 9 companies in 2025. Trend: 2023 $1,058 · 2024 $1,024 · 2025 $5,245
Speaker / faculty: $4,500Food & beverage: $745
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $4,561 |
| Neurocrine BioSciences, Inc. | 4 | $235 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $161 |
| E.R. Squibb & Sons, L.L.C. | 3 | $67 |
| Axsome Therapeutics, Inc. | 2 | $65 |
| Vanda Pharmaceuticals Inc. | 3 | $63 |
| Otsuka America Pharmaceutical, Inc. | 3 | $63 |
| Alkermes, Inc. | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
Products named: VRAYLAR, INGREZZA, CAPLYTA, COBENFY, Auvelity, FANAPT, REXULTI, ARISTADA.
Industry payments across CO — which companies pay providers there.
